Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT3 receptor antagonist, in the mouse elevated plus-maze von ZHANG, Zhang-Jin, SCHMIDT, Dennis E, DE PAULIS, Tomas, TRIVEDI, Bakula L, ONAIVI, Emmanuel S, EBERT, Michael H, HEWLETT, William A

Volltext

( S)-4-amino-5-chloro-3-iodo-2-methoxy- N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (TRIZAC), a high-affinity ligand for the 5-HT-3 receptor von de Paulis, Tomas, Trivedi, Bakula L., Zhang, Zhang-Jin, Schmidt, Dennis E., Ebert, Michael H., Hewlett, William A.

Volltext

Synthesis and Radiolabeling of (S)-4-Amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the Active Enantiomer of [125I]Iodozacopride, and Re-evaluation of Its 5-HT3 R... von HEWLETT, William A., PAULIS, Tomas DE, MASON, N. Scott, SCHMIDT, Dennis E., TRIVEDI, Bakula L., ZHANG, Zhang-Jin, EBERT, Michael H.

Volltext

Synthesis and 5-HT-3 Receptor Binding of 2- and 3-(Halo)alkoxyl Substituted ( S)- N-(1-Azabicyclo [2.2.2]oct-3-yl)-5-chlorobenzamides as Potential Radioligands von Hewlett, William A, Schmidt, Dennis E, Mason, N.Scott, Trivedi, Bakula L, Ebert, Michael H, de Paulis, Tomas

Volltext

Synthesis and Radiolabeling of (S)-4-Amino-5-iodo-2-methoxy-N-(1-azabicyclo(2.2.2)oct-3-yl)benzamide, the Active Enantiomer of (125I)Iodozacopride, and Re-evaluation of Its 5-HT3 R... von HEWLETT, William A., PAULIS, Tomas DE, MASON, N. Scott, SCHMIDT, Dennis E., TRIVEDI, Bakula L., ZHANG, Zhang-Jin, EBERT, Michael H.

Volltext

Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations von Zhang, Zhang-Jin, Trivedi, Bakula L, de Paulis, Tomas, Schmidt, Dennis E, Hewlett, William A

Volltext

Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain von HEWLETT, W. A, FRIDMAN, S, TRIVEDI, B. L, SCHMIDT, D. E, DE PAULIS, T, EBERT, M. H

Volltext

Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT 3 receptor antagonist, in the mouse elevated plus-maze von Zhang, Zhang-Jin, Schmidt, Dennis E., de Paulis, Tomas, Trivedi, Bakula L., Onaivi, Emmanuel S., Ebert, Michael H., Hewlett, William A.

Volltext

Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer von Chan, Emily, Lafleur, Bonnie, Rothenberg, Mace L, Merchant, Nipun, Lockhart, Albert Craig, Trivedi, Bakula, Chung, Christine H, Coffey, Robert J, Berlin, Jordan D

Volltext